 | • レポートコード：MRC2-11QY04078 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は口腔がん治療のグローバル市場について調査・分析したレポートです。種類別（扁平上皮がん、疣贅がん、小唾液腺がん、リンパ腫）市場規模、用途別（病院・診療所、研究機関、学術機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別口腔がん治療の競争状況、市場シェア ・世界の口腔がん治療市場：種類別市場規模 2015年-2020年（扁平上皮がん、疣贅がん、小唾液腺がん、リンパ腫） ・世界の口腔がん治療市場：種類別市場規模予測 2021年-2026年（扁平上皮がん、疣贅がん、小唾液腺がん、リンパ腫） ・世界の口腔がん治療市場：用途別市場規模 2015年-2020年（病院・診療所、研究機関、学術機関） ・世界の口腔がん治療市場：用途別市場規模予測 2021年-2026年（病院・診療所、研究機関、学術機関） ・北米の口腔がん治療市場分析：米国、カナダ ・ヨーロッパの口腔がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの口腔がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の口腔がん治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの口腔がん治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb、Qilu Pharmaceutical、Teva Pharmaceutical Industries、Eli Lilly And Company、Roche、Merck、Novartis、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring anatomic structure, such as the nasal cavity. Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types: teratoma, adenocarcinoma derived from a major or minor salivary gland, lymphoma from tonsillar or other lymphoid tissue, or melanoma from the pigment-producing cells of the oral mucosa.
There are several types of oral cancers, but around 90% are squamous cell carcinomas, originating in the tissues that line the mouth and lips. Oral or mouth cancer most commonly involves the tongue. It may also occur on the floor of the mouth, cheek lining, gingiva (gums), lips, or palate (roof of the mouth). In 2013 oral cancer resulted in 135,000 deaths up from 84,000 deaths in 1990. Five-year survival rates in the United States are 63%.
Market Analysis and Insights: Global Oral Cancer Treatment Market
The global Oral Cancer Treatment market size is projected to reach US$ 2445.4 million by 2026, from US$ 2343.4 million in 2020, at a CAGR of 4.0%% during 2021-2026.
Global Oral Cancer Treatment Scope and Market Size
Oral Cancer Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol-Myers Squibb
Qilu Pharmaceutical
Teva Pharmaceutical Industries
Eli Lilly And Company
Roche
Merck
Novartis
Pfizer
Market segment by Type, the product can be split into
Squamous Cell Carcinoma
Verrucous Carcinoma
Minor Salivary Gland Carcinomas
Lymphomas
Market segment by Application, split into
Hospitals & Clinics
Research Organization
Academic Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Cancer Treatment Revenue
1.4 Market by Type
1.4.1 Global Oral Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Squamous Cell Carcinoma
1.4.3 Verrucous Carcinoma
1.4.4 Minor Salivary Gland Carcinomas
1.4.5 Lymphomas
1.5 Market by Application
1.5.1 Global Oral Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Research Organization
1.5.4 Academic Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Oral Cancer Treatment Market Perspective (2015-2026)
2.2 Global Oral Cancer Treatment Growth Trends by Regions
2.2.1 Oral Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oral Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Oral Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Oral Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Oral Cancer Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Oral Cancer Treatment Players by Market Size
3.1.1 Global Top Oral Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Oral Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Oral Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oral Cancer Treatment Market Concentration Ratio
3.2.1 Global Oral Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Oral Cancer Treatment Revenue in 2019
3.3 Oral Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Oral Cancer Treatment Product Solution and Service
3.5 Date of Enter into Oral Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oral Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Oral Cancer Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Oral Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Oral Cancer Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Oral Cancer Treatment Market Size (2015-2020)
6.2 Oral Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Oral Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Oral Cancer Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Oral Cancer Treatment Market Size (2015-2020)
7.2 Oral Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Oral Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Oral Cancer Treatment Market Size by Application (2015-2020)
8 China
8.1 China Oral Cancer Treatment Market Size (2015-2020)
8.2 Oral Cancer Treatment Key Players in China (2019-2020)
8.3 China Oral Cancer Treatment Market Size by Type (2015-2020)
8.4 China Oral Cancer Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Oral Cancer Treatment Market Size (2015-2020)
9.2 Oral Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Oral Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Oral Cancer Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Oral Cancer Treatment Market Size (2015-2020)
10.2 Oral Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oral Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Oral Cancer Treatment Market Size by Application (2015-2020)
11 India
11.1 India Oral Cancer Treatment Market Size (2015-2020)
11.2 Oral Cancer Treatment Key Players in India (2019-2020)
11.3 India Oral Cancer Treatment Market Size by Type (2015-2020)
11.4 India Oral Cancer Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Oral Cancer Treatment Market Size (2015-2020)
12.2 Oral Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Oral Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Oral Cancer Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview
13.1.3 Bristol-Myers Squibb Oral Cancer Treatment Introduction
13.1.4 Bristol-Myers Squibb Revenue in Oral Cancer Treatment Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Qilu Pharmaceutical
13.2.1 Qilu Pharmaceutical Company Details
13.2.2 Qilu Pharmaceutical Business Overview
13.2.3 Qilu Pharmaceutical Oral Cancer Treatment Introduction
13.2.4 Qilu Pharmaceutical Revenue in Oral Cancer Treatment Business (2015-2020)
13.2.5 Qilu Pharmaceutical Recent Development
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Details
13.3.2 Teva Pharmaceutical Industries Business Overview
13.3.3 Teva Pharmaceutical Industries Oral Cancer Treatment Introduction
13.3.4 Teva Pharmaceutical Industries Revenue in Oral Cancer Treatment Business (2015-2020)
13.3.5 Teva Pharmaceutical Industries Recent Development
13.4 Eli Lilly And Company
13.4.1 Eli Lilly And Company Company Details
13.4.2 Eli Lilly And Company Business Overview
13.4.3 Eli Lilly And Company Oral Cancer Treatment Introduction
13.4.4 Eli Lilly And Company Revenue in Oral Cancer Treatment Business (2015-2020)
13.4.5 Eli Lilly And Company Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Oral Cancer Treatment Introduction
13.5.4 Roche Revenue in Oral Cancer Treatment Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Oral Cancer Treatment Introduction
13.6.4 Merck Revenue in Oral Cancer Treatment Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Oral Cancer Treatment Introduction
13.7.4 Novartis Revenue in Oral Cancer Treatment Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Pfizer
13.8.1 Pfizer Company Details
13.8.2 Pfizer Business Overview
13.8.3 Pfizer Oral Cancer Treatment Introduction
13.8.4 Pfizer Revenue in Oral Cancer Treatment Business (2015-2020)
13.8.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Oral Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Oral Cancer Treatment Revenue
Table 3. Ranking of Global Top Oral Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oral Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Squamous Cell Carcinoma
Table 6. Key Players of Verrucous Carcinoma
Table 7. Key Players of Minor Salivary Gland Carcinomas
Table 8. Key Players of Lymphomas
Table 9. Global Oral Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Oral Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Oral Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Oral Cancer Treatment Market Share by Regions (2015-2020)
Table 13. Global Oral Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Oral Cancer Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Oral Cancer Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Oral Cancer Treatment Players
Table 20. Global Oral Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Oral Cancer Treatment Market Share by Players (2015-2020)
Table 22. Global Top Oral Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Treatment as of 2019)
Table 23. Global Oral Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Oral Cancer Treatment Product Solution and Service
Table 26. Date of Enter into Oral Cancer Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Oral Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Oral Cancer Treatment Market Size Share by Type (2015-2020)
Table 30. Global Oral Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Oral Cancer Treatment Market Size Share by Application (2015-2020)
Table 32. Global Oral Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Oral Cancer Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Oral Cancer Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Oral Cancer Treatment Market Share (2019-2020)
Table 36. North America Oral Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Oral Cancer Treatment Market Share by Type (2015-2020)
Table 38. North America Oral Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Oral Cancer Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Oral Cancer Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Oral Cancer Treatment Market Share (2019-2020)
Table 42. Europe Oral Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Oral Cancer Treatment Market Share by Type (2015-2020)
Table 44. Europe Oral Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Oral Cancer Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Oral Cancer Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Oral Cancer Treatment Market Share (2019-2020)
Table 48. China Oral Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Oral Cancer Treatment Market Share by Type (2015-2020)
Table 50. China Oral Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Oral Cancer Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Oral Cancer Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Oral Cancer Treatment Market Share (2019-2020)
Table 54. Japan Oral Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Oral Cancer Treatment Market Share by Type (2015-2020)
Table 56. Japan Oral Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Oral Cancer Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Oral Cancer Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Oral Cancer Treatment Market Share (2019-2020)
Table 60. Southeast Asia Oral Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Oral Cancer Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Oral Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Oral Cancer Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Oral Cancer Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Oral Cancer Treatment Market Share (2019-2020)
Table 66. India Oral Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Oral Cancer Treatment Market Share by Type (2015-2020)
Table 68. India Oral Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Oral Cancer Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Oral Cancer Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Oral Cancer Treatment Market Share (2019-2020)
Table 72. Central & South America Oral Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Oral Cancer Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Oral Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Oral Cancer Treatment Market Share by Application (2015-2020)
Table 76. Bristol-Myers Squibb Company Details
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb Product
Table 79. Bristol-Myers Squibb Revenue in Oral Cancer Treatment Business (2015-2020) (Million US$)
Table 80. Bristol-Myers Squibb Recent Development
Table 81. Qilu Pharmaceutical Company Details
Table 82. Qilu Pharmaceutical Business Overview
Table 83. Qilu Pharmaceutical Product
Table 84. Qilu Pharmaceutical Revenue in Oral Cancer Treatment Business (2015-2020) (Million US$)
Table 85. Qilu Pharmaceutical Recent Development
Table 86. Teva Pharmaceutical Industries Company Details
Table 87. Teva Pharmaceutical Industries Business Overview
Table 88. Teva Pharmaceutical Industries Product
Table 89. Teva Pharmaceutical Industries Revenue in Oral Cancer Treatment Business (2015-2020) (Million US$)
Table 90. Teva Pharmaceutical Industries Recent Development
Table 91. Eli Lilly And Company Company Details
Table 92. Eli Lilly And Company Business Overview
Table 93. Eli Lilly And Company Product
Table 94. Eli Lilly And Company Revenue in Oral Cancer Treatment Business (2015-2020) (Million US$)
Table 95. Eli Lilly And Company Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Product
Table 99. Roche Revenue in Oral Cancer Treatment Business (2015-2020) (Million US$)
Table 100. Roche Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Product
Table 104. Merck Revenue in Oral Cancer Treatment Business (2015-2020) (Million US$)
Table 105. Merck Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Product
Table 109. Novartis Revenue in Oral Cancer Treatment Business (2015-2020) (Million US$)
Table 110. Novartis Recent Development
Table 111. Pfizer Business Overview
Table 112. Pfizer Product
Table 113. Pfizer Company Details
Table 114. Pfizer Revenue in Oral Cancer Treatment Business (2015-2020) (Million US$)
Table 115. Pfizer Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Squamous Cell Carcinoma Features
Figure 3. Verrucous Carcinoma Features
Figure 4. Minor Salivary Gland Carcinomas Features
Figure 5. Lymphomas Features
Figure 6. Global Oral Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Research Organization Case Studies
Figure 9. Academic Institutes Case Studies
Figure 10. Oral Cancer Treatment Report Years Considered
Figure 11. Global Oral Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Oral Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Oral Cancer Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Oral Cancer Treatment Market Share by Players in 2019
Figure 16. Global Top Oral Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Oral Cancer Treatment Revenue in 2019
Figure 18. North America Oral Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Oral Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Oral Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Oral Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Oral Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Oral Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Oral Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
副腎皮質がん治療の世界市場（～2026年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…- 小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…
- 尿路上皮がん治療の世界市場（～2026年） Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …
- 経口血糖降下薬（OAD）治療の世界市場（～2026年） Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabet…
- 下咽頭がん治療の世界市場（～2026年） Market Analysis and Insights: Global Hypopharyngeal Cancer Treatment Market The global Hypopharyngeal Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hypopharyngeal Cancer Treatment Scope and Market Si…